Advertisement

Clinical Reviews in Allergy

, Volume 4, Issue 1, pp 87–99 | Cite as

Treatment of atopic dermatitis: Old and new modalities

  • Arthur R. Rhodes
Article
  • 32 Downloads

Conclusions

There is no single effective management that is useful for all phases of AD. The recognition of multiple cutaneous morphologic reacting patterns in AD (ie, follicular eczema), vesicular and crusted superinfection with herpes simplex andStaphylococcus aureus, lichenification, lackluster skin, excoriation, and exfoliative erythroderma) helps to determine more directed therapy and elimination of flare factors. Management of AD requires recognition and amelioration of identifiable flare factors, education of patients and families about these factors and the chronic and relapsing nature of disease, the adjunctive and temporary use of topical corticosteroids and systemic H1 antihistamines, and the judicious use of antistaphylococcal antibiotics. Patients, family, and physician must understand that the main goal in treatment is control of the disease, not cure. Definitive therapy of AD awaits a clearer understanding of pathophysiology of disease.

Keywords

Atopic Dermatitis Dermatol Topical Corticosteroid Fluocinolone Acetonide Stearyl Alcohol 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kitamura K: Zur Frage aes Kinderekzems. Hautarzt 17:53–55, 1966PubMedGoogle Scholar
  2. 2.
    Sassagawa S: Studies on the dry form of eczema in childhood. Jap J Dermatol 77:62–87, 1967Google Scholar
  3. 3.
    Ofuji S, Uehara M: Follicular eruptions of atopic dermatitis. Arch Dermatol 107:54–55, 1973PubMedCrossRefGoogle Scholar
  4. 4.
    Rajka G: Atopic dermatitis, in Major Problems in Dermatology (ed A Rook). London, Saunders, 1975Google Scholar
  5. 5.
    Goldblum RW, Piper WN: Artificial lichenification produced by a scratching machine. J Invest Dermatol 22:405–415, 1954PubMedGoogle Scholar
  6. 6.
    Leyden JJ, Baker DA: Localized herpes simplex infection in atopic dermatitis. Arch Dermatol 115:311–312, 1979PubMedCrossRefGoogle Scholar
  7. 7.
    Hanifin JM, Rogge JL: Staphylococcal infections in patients with atopic dermatitis. Arch Dermatol 113:1383–1386, 1977PubMedCrossRefGoogle Scholar
  8. 8.
    Aly R, Maibach HI, Shinefield HR: Microbial flora of atopic dermatitis. Arch Dermatol 113:780–782, 1977PubMedCrossRefGoogle Scholar
  9. 9.
    Noble WC: Skin carriage of Micrococcaceae. J Clin Pathol 22:249–253, 1969PubMedCrossRefGoogle Scholar
  10. 10.
    Gloor M, Peters G, Stoika D: On the resident flora in unaffected skin of patients with atopic dermatitis and healthy controls. Dermatologica 164:258–265, 1982PubMedGoogle Scholar
  11. 11.
    Leyden JJ, Marples RR, Kligman AM: Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol 90:525–530, 1974PubMedCrossRefGoogle Scholar
  12. 12.
    Wilson PE, White PM, Noble WC: Infection in a hospital for patients with diseases of the skin. J Hygiene 69:125–132, 1971Google Scholar
  13. 13.
    Noble WC: The contribution of individual patients to spread of infections. Br J Dermatol 85:24–29, 1971PubMedCrossRefGoogle Scholar
  14. 14.
    Pillsbury DM, Nichols AC: Bacterial flora of the normal and infectious skin: An evaluation of various methods of performing skin cultures. J Invest Dermatol 7:365–373, 1946Google Scholar
  15. 15.
    Bibel DJ, Aly R, Shinefield HR, Maibach HI, Strauss WC: Importance of the keratinized epithelial cell in bacterial adherence. J Invest Dermatol 79:250–252, 1982PubMedCrossRefGoogle Scholar
  16. 16.
    Hasan T, Jansen CT: Erythroderma: A follow-up of fifty cases. J Am Acad Dermatol 8:836–840, 1983PubMedCrossRefGoogle Scholar
  17. 17.
    Nicholis GD, Helwig EB: Exfoliative dermatitis: A clinicopathologic study of 135 cases. Arch Dermatol 108:788–797, 1973CrossRefGoogle Scholar
  18. 18.
    Abrahams I, McCarthy JR, Sanders SL: 101 cases of exfoliative dermatitis. Arch Dermatol 87:96–101, 1963PubMedGoogle Scholar
  19. 19.
    Scholtz JR: Management of atopic dermatitis. Calif Med 102:210–216, 1965PubMedGoogle Scholar
  20. 20.
    Jacobs AH: Local management of atopic dermatitis in infants and children. Clin Pediatr 8:201–203, 1969CrossRefGoogle Scholar
  21. 21.
    Ayres S, Jr, Mihan R: Treatment of atopic dermatitis with the Scholtz regimen. Arch Dermatol 113:1616, 1977PubMedCrossRefGoogle Scholar
  22. 22.
    Buckley RH: Atopic dermatitis: A new therapeutic regimen. JAMA 250:2926–2927, 1983CrossRefGoogle Scholar
  23. 23.
    Atherton DJ, Sewell M, Soothill JF, Wells RS, Chilvers CED: A double-blind controlled crossover trial of an antigen-avoidance diet in atopic eczema. Lancet 1:401–403, 1978PubMedCrossRefGoogle Scholar
  24. 24.
    Bock SA, Lee W-Y, Remigio LK, May CD: Studies of hypersensitivity reactions to foods in infants and children. J Allergy Clin Immunol 62:327–334, 1978PubMedCrossRefGoogle Scholar
  25. 25.
    Sampson HA: Role of immediate food hypersensitivity in the pathogenesis of atopic dermatitis. J Allergy Clin Immunol 71:473–480, 1983PubMedCrossRefGoogle Scholar
  26. 26.
    Fuenmayor MCD, Champion RH: Specific hyposensitization in atopic dermatitis. Brit J Dermatol 101:697–700, 1979CrossRefGoogle Scholar
  27. 27.
    Bonifazi E, Garofalo L, Monterisi A, Meneghini CL: History of food allergy, RAST, and challenge test in atopic dermatitis. Acta Dermato Vener, Suppl 92:91–93, 1980Google Scholar
  28. 28.
    Hammar H: Provocation with cow’s milk and cereals in atopic dermatitis. Acta Derm Venereol 57:159–163, 1977PubMedGoogle Scholar
  29. 29.
    Bierman CW, Shapiro GG, Christie DL: Eczema, rickets and food allergy. J Allergy Clin Immunol 61:119–127, 1978PubMedCrossRefGoogle Scholar
  30. 30.
    Douglas WW: Histamine and antihistamines, 5-hydroxytryptamine and antagonists, in The Pharmacological Basis of Therapeutics, 5th ed.,(ed LS Goodman and A Gilman). New York, Macmillian, 1975, pp 590–629Google Scholar
  31. 31.
    Foulds IS, Mackie RM: A double-blind trial of the H2 receptor antagonist Cimetidine and the Hi receptor antagonist promethazine hydrochloride in the treatment of atopic dermatitis. Clin Allerg 11:319–323, 1981CrossRefGoogle Scholar
  32. 32.
    Wright S, Burton JL: Oral evening-primrose seed oil improves atopic eczema. Lancet 1:1120–1122, 1982CrossRefGoogle Scholar
  33. 33.
    Haider SA: Treatment of atopic eczema in children: Use of topical sodium cromoglycate, in The Mast Cell-Its Role in Health and Disease (ed J Pepys and AM Edwards). Pub Pitman Medical, Turnbridge Wells, England, 1979, pp 570–576Google Scholar
  34. 34.
    Haider SA: Treatment of atopic eczema in children: Clinical trial of 10% sodium cromoglycate ointment. Brit Med J 1:1570–1572, 1977PubMedGoogle Scholar
  35. 35.
    Thirumoothy T, Greaves M: Disodium cromoglycate ointment in atopic eczema. Brit Med J 2:500–501, 1978CrossRefGoogle Scholar
  36. 36.
    Cramers M, Jensen J, Kragbelle K, Afzelius H, Overgaard Petersen H, Zacharine H, Thestrup-Pedersen K, Thulin H, Thormann J, Herlin T: Experimental treatment in atopic dermatitis: Immunological background and preliminary results. Acta Dermato Vener, Suppl 92:121–127, 1980Google Scholar
  37. 37.
    Shaw R: Cromolyn therapy in chronic infantile eczema. Arch Dermatol 111:1537, 1975 (letter)Google Scholar
  38. 38.
    Larsen FS, Jacobsen KU Atopie dermatitis and systemic treatment with a new chromone compound (FPL 57787): A double blind trial. Acta Dermato Vener, Suppl 92:128–129, 1980Google Scholar
  39. 39.
    Atherton DJ, Soothill JF, Eldridge J: A controlled trial of oral sodium cromoglycate in atopic eczema. Br J Dermatol 106:681–685, 1982PubMedCrossRefGoogle Scholar
  40. 40.
    Molkhou P, Wagnet JC: Food allergy and atopic dermatitis in children: Treatment with oral sodium cromoglycate. Ann Allergy 47:173–178, 1981PubMedGoogle Scholar
  41. 41.
    Kaplan RJ, Daman L, Rosenberg EW, Feigenbaum S: Topical use of caffeine with hydrocortisone in the treatment of atopic dermatitis. Arch Dermatol 114:60–62, 1978PubMedCrossRefGoogle Scholar
  42. 42.
    Munro DD: Corticotrophin and tetracosactrin depot-self-administered for the treatment of eczema. Brit J Dermatol 94, Suppl 12:135–138, 1976CrossRefGoogle Scholar
  43. 43.
    Morrison JG, Schulz EJ: Treatment of eczema with cyclophosphamide and azothioprine. Br J Dermatol 98:203–207, 1979CrossRefGoogle Scholar
  44. 44.
    Kang K, Cooper KD, Hanifin JM: Thymopoietin pentapeptide (TP-5) improves clinical parameters and lymphocyte subpopulations in atopic dermatitis. J Am Acad Dermatol 8:372–377, 1983PubMedCrossRefGoogle Scholar
  45. 45.
    Havmark A, Ekre HP: Failure of transfer factor in atopic dermatitis. Acta Dermato Vener 58:497–499, 1978Google Scholar
  46. 46.
    Cramers M, Jensen JR, Kragballe K, Herlin T, Zachariae H, Thestrup-Pedersen K: Transfer factor in atopic dermatitis. Dermatologica 164:369–378, 1982PubMedCrossRefGoogle Scholar
  47. 47.
    Alomar A, Gimenze-Camarasa J, de Moragas JM: The use of levamisole in atopic dermatitis: A prospective study. Arch Dermatol 114:1316–1319, 1978PubMedCrossRefGoogle Scholar
  48. 48.
    Rajka G: Prurigo Besnier (atopic dermatitis) with special reference to the role of allergic factors, II: The evaluation of the results of skin reactions. Acta Dermato Vener (Stockholm) 41:1–39, 1961Google Scholar
  49. 49.
    Morrison WL, Parrish JA, Fitzpatrick TB: Oral psoralen photochemotherapy of atopic eczema. Brit J Dermatol 98:25–30, 1970CrossRefGoogle Scholar
  50. 50.
    Sannwald C, Ortonne JP, Thivolet J: La photochimiotherapie orale de l’eczema atopique. Dermatologica 159:71–77, 1979PubMedGoogle Scholar
  51. 51.
    Soppi E, Viander M, Soppi A-M, Jansen CT: Cell-mediated immunity in untreated and PUVA-treated atopic dermatitis. J Invest Dermatol 79:213–217, 1982.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 1986

Authors and Affiliations

  • Arthur R. Rhodes
    • 1
    • 2
  1. 1.Division of DermatologyThe Children’s HospitalBoston
  2. 2.the Department of DermatologyHarvard Medical SchoolBoston

Personalised recommendations